According to the latest report by IMARC Group, titled “Biomarker Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global biomarker technologies market reached a value of US$ XX Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026. Biomarker technologies represent reliable and cost-effective detection tools that depend on genetic biomarkers, such as deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), to detect pathogens. These technologies find widespread applications in the early diagnosis of various diseases and disorders. They are also used in drug discovery and development processes and for managing nervous system disorders, infections, cardiovascular diseases, immunological and genetic disorders, cancer, etc. Examples of commonly used biomarker technologies include next-generation sequencing (NGS), polymerase chain reaction (PCR), immunoassay, etc.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Sample Report: https://www.imarcgroup.com/biomarker-technologies-market/requestsample
Biomarker Technologies Market Trends:
The increasing prevalence of cancer and neurological, cardiovascular, and autoimmune diseases is currently driving the biomarker technologies market. This is further being supported by the escalating demand for early diagnosis and effective treatment of numerous ailments. Moreover, increasing investments in drug discovery activities by governing agencies of numerous countries are also contributing to the market growth. Besides this, continuous advancements in biomarker technologies to provide accurate patient stratification are further augmenting the global market. Furthermore, the rising incorporation of digital biomarkers with artificial intelligence (AI), integrated decision-making, machine learning (ML), Big Data, etc., is projected to spur the market for biomarker technologies in the coming years.
Key Market Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Hoffmann-La Roche AG
- Illumina Inc.
- LI-COR Inc.
- Merck KGaA
- PerkinElmer Inc.
- QIAGEN N.V.
- Shimadzu Corporation
- Thermo Fisher Scientific Inc.
- Waters Corporation
Breakup by Test Type:
- Solid Biopsy
- Liquid Biopsy
Breakup by Indication:
- Infectious Diseases
- Autoimmune Disorders
- Cardiovascular Disorders
Breakup by Product:
Breakup by Technology:
- Polymerase Chain Reaction (PCR)
- Next Generation Sequencing (NGS)
Breakup by Application:
- Drug Discovery
- Clinical Diagnostics
- Personalized Medicine
Breakup by Region:
- Middle East and Africa
- North America
- Latin America
Key highlights of the Report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800